MiNK Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell INKT and other ETFs, options, and stocks.About INKT
MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded in 2017 and is headquartered in New York, NY.
INKT Key Statistics
Stock Snapshot
As of today, MiNK Therapeutics(INKT) shares are valued at $12.30. The company's market cap stands at 60.23M, with a P/E ratio of -4.21.
On 2026-01-27, MiNK Therapeutics(INKT) stock traded between a low of $12.30 and a high of $12.83. Shares are currently priced at $12.30, which is 0.0% above the low and -4.1% below the high.
MiNK Therapeutics(INKT) shares are trading with a volume of 10.72K, against a daily average of 9.56K.
In the last year, MiNK Therapeutics(INKT) shares hit a 52-week high of $76.00 and a 52-week low of $4.56.
In the last year, MiNK Therapeutics(INKT) shares hit a 52-week high of $76.00 and a 52-week low of $4.56.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.